John Bettinger, MD
Gastroenterology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 40 years
- University of California, San Francisco School of Medicine, 1986
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bettinger’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G64202 · Current
Licensed to practise in California · since 1988 · expires 2028-01-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$29,954
Medicare paid this office $29,954 for 112 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $11,100 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $4,713 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,889 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,887 | $94 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,132 | $94 |
Procedures Medicare counted
| Colonoscopy | 22 | More than 49% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 47 | More than 62% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of large bowel using a flexible endoscope | 145 | 136 | 168 | 186 | 107 | – |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 132 | 117 | 130 | 152 | 84 | – |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 103 | 103 | 86 | 73 | 37 | 20 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | 23 | 29 | 25 | 23 | 12 |
| Diagnostic exam of large bowel using a flexible endoscope | 29 | 17 | 19 | 15 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
112 Original Medicare patients in 2024. Average age 79 · 85 and older 28% · Women 61% · Also on Medicaid 30% · Health risk score 1.88. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Chronic kidney disease 43% · Depression 40% · Diabetes 38% · Atrial fibrillation 38% · Heart failure 30% · Cancer 24% · COPD 23% · Dementia 18% · Stroke 15%.
The office billed $321,002, Medicare allowed $38,775 and paid $29,954; for 280 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 112 | 280 | 79 | 1.88 | $321,002 | $29,954 |
| 2023 | 343 | 623 | 77 | 1.12 | $1,005,586 | $70,795 |
| 2022 | 624 | 1,165 | 75 | 1.12 | $1,805,890 | $145,683 |
| 2021 | 587 | 1,159 | 75 | 1.16 | $1,335,260 | $138,736 |
| 2020 | 582 | 1,120 | 75 | 1.21 | $588,764 | $138,505 |
| 2019 | 697 | 1,298 | 75 | 1.16 | $653,885 | $155,079 |
| 2018 | 632 | 1,257 | 75 | 1.15 | $631,350 | $149,091 |
| 2017 | 645 | 1,407 | 75 | 1.20 | $699,302 | $167,932 |
| 2016 | 746 | 1,538 | 75 | 1.16 | $770,770 | $182,743 |
| 2015 | 690 | 1,391 | 74 | 1.08 | $691,159 | $180,522 |
| 2014 | 649 | 1,420 | 74 | 1.08 | $696,789 | $176,469 |
| 2013 | 495 | 1,092 | 73 | 1.16 | $499,170 | $130,561 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $18,755 | $223 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $7,959 | $147 |
| Biopsy of large bowel using a flexible endoscope | 107 | $7,185 | $67 |
| Long return visit (40+ min) | 47 | $6,644 | $125 |
| Return visit (30+ min) | 60 | $5,364 | $89 |
| New patient visit (45+ min) | 38 | $3,614 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $3,497 | $67 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $3,151 | $85 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,433 | $187 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,047 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,820 | $101 |
2022: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 152 | $32,536 | $214 |
| New patient visit (45+ min) | 133 | $20,059 | $151 |
| Long return visit (40+ min) | 86 | $16,176 | $162 |
| Return visit (30+ min) | 123 | $14,440 | $110 |
| Biopsy of large bowel using a flexible endoscope | 186 | $11,015 | $59 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 40 | $7,807 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,473 | $166 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $5,815 | $80 |
| New patient visit (60+ min) | 28 | $5,502 | $196 |
| New patient visit (30+ min) | 50 | $5,067 | $101 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $3,816 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,455 | $58 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,191 | $146 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,096 | $84 |
| Short return visit (20+ min) | 19 | $1,551 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,295 | $86 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 17 | $426 | $24 |
2021: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 130 | $28,848 | $222 |
| Return visit (30+ min) | 137 | $15,912 | $105 |
| Biopsy of large bowel using a flexible endoscope | 168 | $14,556 | $87 |
| New patient visit (45+ min) | 90 | $11,770 | $131 |
| Long return visit (40+ min) | 56 | $10,569 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,228 | $170 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $7,412 | $86 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 36 | $6,879 | $191 |
| New patient visit (30+ min) | 56 | $5,243 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $4,434 | $62 |
| Short return visit (20+ min) | 47 | $3,042 | $63 |
| New patient visit (60+ min) | 15 | $2,836 | $189 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,762 | $145 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,491 | $86 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,206 | $184 |
2020: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 117 | $27,415 | $234 |
| New patient visit (45+ min) | 127 | $17,627 | $139 |
| Return visit (30+ min) | 146 | $15,969 | $94 |
| Biopsy of large bowel using a flexible endoscope | 135 | $12,727 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 102 | $8,837 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,471 | $180 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 35 | $6,774 | $194 |
| Short return visit (20+ min) | 84 | $5,617 | $63 |
| Long return visit (40+ min) | 34 | $5,504 | $134 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,329 | $197 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,821 | $166 |
| New patient visit (30+ min) | 32 | $2,400 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,372 | $66 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $1,938 | $84 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,417 | $101 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,151 | $72 |
2019: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 132 | $30,222 | $229 |
| Return visit (30+ min) | 200 | $21,653 | $90 |
| New patient visit (45+ min) | 143 | $19,470 | $136 |
| Biopsy of large bowel using a flexible endoscope | 145 | $13,680 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 103 | $9,384 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,332 | $173 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 39 | $8,038 | $206 |
| Long return visit (40+ min) | 36 | $5,841 | $122 |
| Short return visit (20+ min) | 87 | $5,651 | $58 |
| New patient visit (30+ min) | 58 | $4,562 | $79 |
| Diagnostic exam of large bowel using a flexible endoscope | 29 | $4,062 | $140 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $4,022 | $183 |
| New patient visit (60+ min) | 18 | $3,060 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,308 | $64 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,066 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,832 | $92 |
2018: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 117 | $26,582 | $225 |
| Return visit (30+ min) | 200 | $22,713 | $90 |
| Biopsy of large bowel using a flexible endoscope | 169 | $16,609 | $98 |
| New patient visit (45+ min) | 116 | $14,943 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,406 | $174 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 97 | $9,383 | $96 |
| Long return visit (40+ min) | 37 | $6,381 | $128 |
| Short return visit (20+ min) | 87 | $5,945 | $59 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 29 | $5,789 | $200 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,931 | $197 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,559 | $162 |
| New patient visit (60+ min) | 14 | $2,591 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,541 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,457 | $91 |
| New patient visit (30+ min) | 28 | $2,207 | $79 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,143 | $89 |
2017: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 109 | $24,913 | $226 |
| Return visit (30+ min) | 187 | $21,672 | $91 |
| Biopsy of large bowel using a flexible endoscope | 156 | $16,277 | $102 |
| New patient visit (45+ min) | 116 | $14,951 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $12,246 | $175 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 104 | $9,554 | $90 |
| Short return visit (20+ min) | 134 | $9,091 | $57 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 34 | $6,930 | $198 |
| Long return visit (40+ min) | 40 | $6,106 | $127 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $5,450 | $202 |
| Diagnostic exam of large bowel using a flexible endoscope | 25 | $4,030 | $161 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $3,523 | $90 |
| New patient visit (60+ min) | 18 | $3,294 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,256 | $63 |
| New patient visit (30+ min) | 38 | $3,085 | $81 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $710 | $34 |
| Short return visit | 18 | $684 | $36 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $161 | $15 |
2016: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 126 | $28,223 | $224 |
| Return visit (30+ min) | 239 | $25,911 | $92 |
| Biopsy of large bowel using a flexible endoscope | 191 | $18,876 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 155 | $15,544 | $100 |
| New patient visit (45+ min) | 96 | $13,091 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $11,602 | $173 |
| Short return visit (20+ min) | 162 | $10,578 | $60 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 39 | $8,151 | $209 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 39 | $8,040 | $206 |
| Diagnostic exam of large bowel using a flexible endoscope | 33 | $5,632 | $166 |
| Long return visit (40+ min) | 36 | $4,946 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $3,496 | $62 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,213 | $97 |
| New patient visit (60+ min) | 16 | $2,622 | $164 |
| New patient visit (30+ min) | 26 | $1,484 | $57 |
| Short return visit | 31 | $1,060 | $34 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $644 | $34 |
2015: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 105 | $28,488 | $264 |
| New patient visit (45+ min) | 166 | $23,497 | $142 |
| Biopsy of large bowel using a flexible endoscope | 155 | $21,900 | $140 |
| Return visit (30+ min) | 141 | $15,353 | $91 |
| Short return visit (20+ min) | 171 | $12,326 | $60 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 116 | $11,443 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $10,968 | $174 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 42 | $9,448 | $225 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | $6,120 | $219 |
| Diagnostic exam of large bowel using a flexible endoscope | 30 | $5,634 | $188 |
| New patient visit (30+ min) | 42 | $3,740 | $89 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,500 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,957 | $63 |
| Short return visit | 28 | $1,076 | $38 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $845 | $34 |
| New patient visit (15+ min) | 12 | $691 | $58 |
2014: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 90 | $23,630 | $260 |
| Biopsy of large bowel using a flexible endoscope | 148 | $23,019 | $154 |
| Return visit (30+ min) | 183 | $20,167 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 144 | $12,499 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $12,436 | $170 |
| New patient visit (45+ min) | 82 | $10,840 | $132 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 47 | $10,722 | $228 |
| Short return visit (20+ min) | 149 | $10,590 | $58 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 35 | $7,934 | $227 |
| Diagnostic exam of large bowel using a flexible endoscope | 28 | $4,950 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,836 | $61 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $2,587 | $83 |
| Long return visit (40+ min) | 18 | $2,572 | $122 |
| New patient visit (30+ min) | 25 | $2,237 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,873 | $89 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 29 | $1,206 | $34 |
| Short return visit | 21 | $793 | $38 |
2013: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 73 | $18,658 | $256 |
| Return visit (30+ min) | 145 | $15,907 | $86 |
| Biopsy of large bowel using a flexible endoscope | 103 | $14,397 | $140 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $11,668 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,691 | $167 |
| New patient visit (45+ min) | 67 | $8,428 | $126 |
| Short return visit (20+ min) | 118 | $8,191 | $62 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $4,601 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $4,320 | $60 |
| Long return visit (40+ min) | 25 | $3,938 | $119 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,691 | $231 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $3,676 | $153 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,001 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,711 | $114 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $940 | $32 |
Drugs they prescribed that Part D paid
$16,086
Pharmacies billed $16,086 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 107) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
89 generic and 18 brand-name prescriptions · $16,086 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Misoprostol | 12 | $2,284 | $190 |
| Omeprazole | 26 | $446 | $17 |
| Pantoprazole | 17 | $435 | $26 |
Year by year
| 2024 | 107 | 52 | 0% (0) | 17% | $16,086 |
| 2023 | 889 | 266 | 0% (0) | 19% | $788,007 |
| 2022 | 1,403 | 438 | None | 30% | $1,046,046 |
| 2021 | 1,523 | 445 | 0% (0) | 25% | $978,820 |
| 2020 | 1,458 | 359 | None | 22% | $742,225 |
| 2019 | 1,482 | 355 | 0% (0) | 24% | $512,430 |
| 2018 | 1,587 | 344 | None | 24% | $549,503 |
| 2017 | 1,460 | 341 | 0% (0) | None | $526,808 |
| 2016 | 1,253 | 311 | 0% (0) | None | $693,359 |
| 2015 | 866 | 207 | None | 32% | $415,131 |
| 2014 | 852 | 210 | None | 31% | $137,924 |
| 2013 | 552 | 121 | None | 24% | $72,743 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Stelara | 18 | $498,947 | $27,719 |
| Creon | 12 | $58,245 | $4,854 |
| Mesalamine | 50 | $43,453 | $869 |
| Linzess | 36 | $32,628 | $906 |
| Xifaxan | 11 | $30,991 | $2,817 |
| Budesonide Ec | 32 | $16,118 | $504 |
| Trulance | 14 | $10,915 | $780 |
| Ursodiol | 15 | $5,080 | $339 |
| Esomeprazole Magnesium | 44 | $5,015 | $114 |
| Clenpiq | 27 | $4,736 | $175 |
| Dexlansoprazole Dr | 12 | $4,598 | $383 |
| Omeprazole | 258 | $4,413 | $17 |
| Pantoprazole | 91 | $2,544 | $28 |
| Sod Sulf-Potass Sulf-Mag Sulf | 23 | $1,878 | $82 |
| Rabeprazole | 20 | $1,532 | $77 |
| Famotidine | 58 | $881 | $15 |
| Lansoprazole | 35 | $774 | $22 |
2022: 24 drugs
| Stelara | 25 | $665,457 | $26,618 |
| Creon | 21 | $78,501 | $3,738 |
| Linzess | 59 | $48,427 | $821 |
| Mesalamine | 57 | $43,734 | $767 |
| Xifaxan | 12 | $38,144 | $3,179 |
| Budesonide Ec | 36 | $19,280 | $536 |
| Aciphex | 14 | $18,522 | $1,323 |
| Suprep | 112 | $12,819 | $114 |
| Clenpiq | 65 | $10,906 | $168 |
| Dexilant | 13 | $7,981 | $614 |
| Omeprazole | 366 | $6,952 | $19 |
| Ursodiol | 18 | $5,517 | $307 |
| Budesonide Dr | 19 | $4,996 | $263 |
| Movantik | 12 | $4,709 | $392 |
| Pantoprazole | 140 | $3,659 | $26 |
| Esomeprazole Magnesium | 52 | $2,252 | $43 |
| Famotidine | 70 | $1,981 | $28 |
| Rabeprazole | 29 | $1,927 | $66 |
| Colesevelam | 11 | $1,865 | $170 |
| Sod Sulf-Potass Sulf-Mag Sulf | 13 | $1,099 | $85 |
| Lansoprazole | 32 | $976 | $30 |
| Entecavir | 11 | $857 | $78 |
| Azathioprine | 14 | $298 | $21 |
| Dicyclomine | 13 | $144 | $11 |
2021: 21 drugs
| Stelara | 26 | $656,352 | $25,244 |
| Mesalamine | 74 | $63,456 | $858 |
| Creon | 14 | $38,225 | $2,730 |
| Linzess | 35 | $26,382 | $754 |
| Suprep | 151 | $16,880 | $112 |
| Dexilant | 22 | $15,392 | $700 |
| Omeprazole | 501 | $9,556 | $19 |
| Budesonide Ec | 32 | $8,704 | $272 |
| Clenpiq | 46 | $7,480 | $163 |
| Budesonide Dr | 30 | $4,441 | $148 |
| Mercaptopurine | 13 | $3,928 | $302 |
| Pantoprazole | 152 | $3,189 | $21 |
| Rabeprazole | 46 | $3,044 | $66 |
| Famotidine | 67 | $1,722 | $26 |
| Esomeprazole Magnesium | 18 | $1,632 | $91 |
| Lansoprazole | 47 | $1,151 | $24 |
| Spironolactone | 21 | $420 | $20 |
| Lactulose | 11 | $286 | $26 |
| Prednisone | 14 | $220 | $16 |
| Dicyclomine | 12 | $133 | $11 |
| Amoxicillin-Clavulanate Potass | 12 | $120 | $10 |
2020: 23 drugs
| Stelara | 18 | $429,428 | $23,857 |
| Mesalamine | 87 | $59,158 | $680 |
| Creon | 23 | $41,114 | $1,788 |
| Linzess | 28 | $21,778 | $778 |
| Budesonide Ec | 47 | $14,484 | $308 |
| Trulance | 20 | $12,801 | $640 |
| Aciphex | 11 | $12,060 | $1,096 |
| Dexilant | 22 | $11,077 | $504 |
| Suprep | 84 | $8,920 | $106 |
| Omeprazole | 520 | $8,905 | $17 |
| Clenpiq | 31 | $4,647 | $150 |
| Esomeprazole Magnesium | 42 | $3,716 | $88 |
| Welchol | 12 | $2,805 | $234 |
| Rabeprazole | 39 | $2,740 | $70 |
| Pantoprazole | 136 | $2,725 | $20 |
| Lansoprazole | 50 | $1,208 | $24 |
| Famotidine | 41 | $1,111 | $27 |
| Diphenoxylate-Atropine | 19 | $657 | $35 |
| Lactulose | 22 | $285 | $13 |
| Prednisone | 20 | $260 | $13 |
| Spironolactone | 17 | $157 | $9 |
| Dicyclomine | 12 | $150 | $12 |
| Furosemide | 13 | $27 | $2 |
2019: 25 drugs
| Linzess | 64 | $36,671 | $573 |
| Creon | 19 | $32,036 | $1,686 |
| Asacol Hd | 17 | $29,971 | $1,763 |
| Mesalamine | 41 | $29,592 | $722 |
| Budesonide Ec | 58 | $26,968 | $465 |
| Aciphex | 11 | $12,337 | $1,122 |
| Omeprazole | 476 | $10,210 | $21 |
| Trulance | 18 | $9,725 | $540 |
| Dexilant | 16 | $8,259 | $516 |
| Suprep | 73 | $7,285 | $100 |
| Esomeprazole Magnesium | 90 | $6,682 | $74 |
| Clenpiq | 37 | $5,076 | $137 |
| Rabeprazole | 60 | $4,746 | $79 |
| Vancomycin | 15 | $2,475 | $165 |
| Pantoprazole | 91 | $2,141 | $24 |
| Lansoprazole | 47 | $957 | $20 |
| Amiloride | 12 | $794 | $66 |
| Diphenoxylate-Atropine | 19 | $792 | $42 |
| Ranitidine | 27 | $755 | $28 |
| Entecavir | 11 | $623 | $57 |
| Famotidine | 27 | $421 | $16 |
| Dicyclomine | 31 | $401 | $13 |
| Prednisone | 22 | $259 | $12 |
| Spironolactone | 21 | $230 | $11 |
| Lactulose | 11 | $209 | $19 |
2018: 29 drugs
| Humira | 12 | $116,397 | $9,700 |
| Linzess | 81 | $35,729 | $441 |
| Budesonide Ec | 73 | $34,707 | $475 |
| Creon | 13 | $30,949 | $2,381 |
| Xifaxan | 11 | $19,707 | $1,792 |
| Asacol Hd | 12 | $18,604 | $1,550 |
| Mesalamine | 26 | $18,403 | $708 |
| Dexilant | 31 | $15,675 | $506 |
| Esomeprazole Magnesium | 102 | $13,205 | $129 |
| Aciphex | 11 | $12,331 | $1,121 |
| Omeprazole | 544 | $9,477 | $17 |
| Suprep | 73 | $6,890 | $94 |
| Ursodiol | 16 | $5,486 | $343 |
| Trulance | 12 | $4,619 | $385 |
| Lansoprazole | 55 | $2,150 | $39 |
| Rabeprazole | 25 | $1,644 | $66 |
| Prepopik | 12 | $1,550 | $129 |
| Pantoprazole | 81 | $1,320 | $16 |
| Mercaptopurine | 20 | $1,315 | $66 |
| Ranitidine | 35 | $558 | $16 |
| Polyethylene Glycol 3350 | 25 | $527 | $21 |
| Metoclopramide | 12 | $319 | $27 |
| Lactulose | 15 | $308 | $21 |
| Famotidine | 24 | $296 | $12 |
| Dicyclomine | 28 | $295 | $11 |
| Diphenoxylate-Atropine | 12 | $291 | $24 |
| Bumetanide | 12 | $159 | $13 |
| Spironolactone | 20 | $156 | $8 |
| Furosemide | 27 | $81 | $3 |
2017: 24 drugs
| Humira | 15 | $66,948 | $4,463 |
| Budesonide Ec | 59 | $34,753 | $589 |
| Lialda | 16 | $21,208 | $1,326 |
| Linzess | 51 | $20,012 | $392 |
| Mesalamine | 18 | $19,231 | $1,068 |
| Dexilant | 46 | $16,553 | $360 |
| Creon | 13 | $14,893 | $1,146 |
| Welchol | 29 | $11,597 | $400 |
| Esomeprazole Magnesium | 74 | $10,515 | $142 |
| Suprep | 76 | $6,686 | $88 |
| Omeprazole | 507 | $6,295 | $12 |
| Ursodiol | 11 | $3,493 | $318 |
| Apriso | 13 | $2,872 | $221 |
| Mercaptopurine | 19 | $1,633 | $86 |
| Lansoprazole | 49 | $1,550 | $32 |
| Pantoprazole | 119 | $1,299 | $11 |
| Rabeprazole | 21 | $955 | $45 |
| Polyethylene Glycol 3350 | 28 | $577 | $21 |
| Ranitidine | 31 | $424 | $14 |
| Diphenoxylate-Atropine | 16 | $413 | $26 |
| Famotidine | 15 | $227 | $15 |
| Ondansetron | 16 | $189 | $12 |
| Dicyclomine | 16 | $126 | $8 |
| Furosemide | 16 | $79 | $5 |
2016: 24 drugs
| Humira | 12 | $46,988 | $3,916 |
| Budesonide Ec | 58 | $32,573 | $562 |
| Asacol Hd | 21 | $26,075 | $1,242 |
| Lialda | 19 | $20,751 | $1,092 |
| Dexilant | 55 | $18,786 | $342 |
| Delzicol | 18 | $14,128 | $785 |
| Esomeprazole Magnesium | 57 | $12,714 | $223 |
| Nexium | 21 | $12,584 | $599 |
| Aciphex | 11 | $10,459 | $951 |
| Linzess | 23 | $8,359 | $363 |
| Welchol | 15 | $6,166 | $411 |
| Omeprazole | 461 | $6,156 | $13 |
| Ursodiol | 12 | $3,190 | $266 |
| Suprep | 33 | $2,717 | $82 |
| Prepopik | 22 | $2,595 | $118 |
| Balsalazide Disodium | 19 | $2,211 | $116 |
| Mercaptopurine | 17 | $1,752 | $103 |
| Lansoprazole | 20 | $1,384 | $69 |
| Pantoprazole | 65 | $842 | $13 |
| Rabeprazole | 22 | $820 | $37 |
| Polyethylene Glycol 3350 | 21 | $427 | $20 |
| Ranitidine | 17 | $240 | $14 |
| Dicyclomine | 25 | $157 | $6 |
| Furosemide | 12 | $41 | $3 |
2015: 18 drugs
| Budesonide Ec | 36 | $30,496 | $847 |
| Nexium | 43 | $25,100 | $584 |
| Asacol Hd | 18 | $19,343 | $1,075 |
| Linzess | 39 | $14,042 | $360 |
| Aciphex | 12 | $12,346 | $1,029 |
| Delzicol | 14 | $11,384 | $813 |
| Dexilant | 31 | $8,337 | $269 |
| Ursodiol | 16 | $7,626 | $477 |
| Welchol | 20 | $6,075 | $304 |
| Omeprazole | 277 | $4,198 | $15 |
| Mercaptopurine | 17 | $2,440 | $144 |
| Suprep | 28 | $2,253 | $80 |
| Pantoprazole | 105 | $1,269 | $12 |
| Lansoprazole | 16 | $627 | $39 |
| Polyethylene Glycol 3350 | 19 | $287 | $15 |
| Ondansetron | 13 | $212 | $16 |
| Dicyclomine | 17 | $45 | $3 |
| Furosemide | 13 | $43 | $3 |
2014: 19 drugs
| Budesonide Ec | 33 | $30,877 | $936 |
| Nexium | 59 | $28,310 | $480 |
| Aciphex | 14 | $10,438 | $746 |
| Asacol Hd | 11 | $7,694 | $699 |
| Dexilant | 40 | $7,452 | $186 |
| Ursodiol | 17 | $6,323 | $372 |
| Linzess | 24 | $6,285 | $262 |
| Omeprazole | 253 | $4,299 | $17 |
| Welchol | 17 | $3,924 | $231 |
| Rabeprazole | 19 | $1,587 | $84 |
| Mercaptopurine | 13 | $1,417 | $109 |
| Suprep | 17 | $1,343 | $79 |
| Ranitidine | 23 | $1,165 | $51 |
| Pantoprazole | 102 | $1,090 | $11 |
| Lansoprazole | 18 | $755 | $42 |
| Ondansetron | 12 | $206 | $17 |
| Peg-3350 | 11 | $205 | $19 |
| Lactulose | 11 | $174 | $16 |
| Dicyclomine | 16 | $57 | $4 |
2013: 6 drugs
| Budesonide Ec | 21 | $19,946 | $950 |
| Nexium | 34 | $15,332 | $451 |
| Dexilant | 25 | $4,048 | $162 |
| Omeprazole | 216 | $4,031 | $19 |
| Lansoprazole | 21 | $1,993 | $95 |
| Pantoprazole | 87 | $1,639 | $19 |
Money from drug and device companies
$259 in 2023
| 2023 | 7 | 11 | None | $259 |
| 2022 | 7 | 25 | None | $515 |
| 2021 | 3 | 12 | None | $245 |
| 2020 | 9 | 10 | None | $194 |
| 2019 | 9 | 31 | None | $468 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Nestle Healthcare Nutrition | Zenpep | $60 | 2 payments
|
| Janssen Biotech | Stelara | $59 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $50 | 2 payments
|
| AbbVie | Skyrizi | $33 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $24 | 1 payment
|
| Ardelyx | Ibsrela | $18 | 1 payment
|
See all 11 published payments
| Nestle Healthcare Nutrition | Meals · 2023-05-23 | Zenpep | $33 |
| Janssen Biotech | Meals · 2023-05-18 | Stelara | $31 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2023-05-03 | Xifaxan | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2023-04-24 | Entyvio | $28 |
| AbbVie | Meals · 2023-03-28 | Skyrizi | $17 |
| Celgene | Meals · 2023-03-23 | None | $16 |
| Nestle Healthcare Nutrition | Meals · 2023-03-09 | Zenpep | $27 |
| Ardelyx | Meals · 2023-02-05 | Ibsrela | $18 |
| Janssen Biotech | Meals · 2023-01-26 | Stelara | $28 |
| AbbVie | Meals · 2023-01-12 | Rinvoq | $16 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2023-01-10 | Entyvio | $21 |
See earlier years (2022, 2021, 2020, 2019)
2022: $515
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $169 | 9 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $111 | 5 payments
|
| Abbvie | Humira | $87 | 4 payments
|
| Janssen Biotech | Stelara | $68 | 3 payments
|
| Ferring Pharmaceuticals | Cimzia | $35 | 2 payments
|
| Ironwood Pharmaceuticals | Linzess | $25 | 1 payment
|
| RedHill Biopharma | Talicia | $21 | 1 payment
|
2021: $245
| AbbVie | Humira | $151 | 8 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $71 | 3 payments
|
| Ironwood Pharmaceuticals | Linzess | $23 | 1 payment
|
2020: $194
| Takeda Pharmaceuticals U.S.A. | Entyvio | $51 | 2 payments
|
| RedHill Biopharma | Aemcolo | $25 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $23 | 1 payment
|
| AbbVie | Humira | $22 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $20 | 1 payment
|
| Gilead Sciences | None | $14 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $14 | 1 payment
|
| Allergan | Zenpep | $12 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $11 | 1 payment
|
2019: $468
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $141 | 12 payments
|
| AbbVie | Mavyret | $135 | 9 payments
|
| Janssen Biotech | Stelara | $72 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $36 | 2 payments
|
| Apollo Endosurgery US | Overstitch | $28 | 1 payment
|
| Pfizer | Xeljanz | $17 | 1 payment
|
| Daiichi Sankyo | Injectafer | $15 | 1 payment
|
| Gilead Sciences | None | $13 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $12 | 1 payment
|
Professional record
- NPI
- 1225037500
- Licence
- CA G64202California G64202: Current · expires 2028-01-31
- Trained
- University of California, San Francisco School of Medicine, 1986 · 40 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NM 23820
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 200 Tamal Plz, Ste 200, Corte Madera, CA, 94925
- NPI first listed
- 2005-07-19
- NPI last updated
- 2021-02-24
- NPI record certified
- 2021-02-24
This is when the NPI record was last certified, not a medical board exam.